Login / Signup

Muscle ultrasound is a responsive biomarker in facioscapulohumeral dystrophy.

Rianne J M GoselinkTim H A SchreuderKarlien MulNicol C VoermansCorrie E ErasmusBaziel G M van EngelenNens van Alfen
Published in: Neurology (2020)
This study provides Class I evidence that in patents with FSHD1, MUS findings correlate with baseline FSHD clinical scores.
Keyphrases
  • magnetic resonance imaging
  • muscular dystrophy
  • early onset
  • cancer therapy
  • ultrasound guided
  • computed tomography
  • drug delivery
  • duchenne muscular dystrophy